Literature DB >> 10191119

A murine model for juvenile NCL: gene targeting of mouse Cln3.

N D Greene1, D L Bernard, P E Taschner, B D Lake, N de Vos, M H Breuning, R M Gardiner, S E Mole, R L Nussbaum, H M Mitchison.   

Abstract

JNCL is a neurodegenerative disease of childhood caused by mutations in the CLN3 gene. A mouse model for JNCL was created by disrupting exons 1-6 of Cln3, resulting in a null allele. Cln3 null mice appear clinically normal at 5 months of age; however, like JNCL patients, they exhibit intracellular accumulation of autofluorescent material. A second approach will generate mice in which exons 7 and 8 of Cln3 are deleted, mimicking the common mutation in JNCL patients. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191119     DOI: 10.1006/mgme.1999.2828

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  7 in total

1.  A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Kwi-Hye Kim; Qinwen Mao; Sandy Price; Shannon L Macauley; Richard L Sidman; Michael M Shen; Qi Zhao; Marco A Passini; Beverly L Davidson; Gregory R Stewart; Peter Lobel
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

2.  Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.

Authors:  Chun-Hung Chan; Hannah M Mitchison; David A Pearce
Journal:  Hum Mol Genet       Date:  2008-08-04       Impact factor: 6.150

Review 3.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 4.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

5.  Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Haiyan Zheng; Caifeng Zhao; Amenah Soherwardy; Dirk F Moore; Peter Lobel
Journal:  Mol Cell Proteomics       Date:  2019-09-09       Impact factor: 5.911

Review 6.  Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward.

Authors:  Jean Bennett
Journal:  Mol Ther       Date:  2017-04-05       Impact factor: 12.910

7.  Retinal degeneration in mice and humans with neuronal ceroid lipofuscinosis type 8.

Authors:  Elyse M Salpeter; Brian C Leonard; Antonio J Lopez; Christopher J Murphy; Sara Thomasy; Denise M Imai; Kristin Grimsrud; K C Kent Lloyd; Jiong Yan; Rossana Sanchez Russo; Suma P Shankar; Ala Moshiri
Journal:  Ann Transl Med       Date:  2021-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.